InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Discover the complete record of transactions filed by Okey Stephanie, Director. Director active across 2 companies, notably Crinetics Pharmaceuticals, Inc.. In total, 6 disclosures have been published. Total volume traded: €316k. The latest transaction was filed on 3 March 2026 — Cession. Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
US$101,7423,000 shares@ US$33.91390.0023% mcap100.0% of flow
Common Stock
SEC:0001628280-26-014775·
€101,7423,000 shares@ €33.91390.0023% mcap50.0% of flow
Common Stock
SEC:0001628280-26-014775:0·
03,200 shares0
Common Stock
SEC:0001179110-22-000388·
03,200 shares0
Common Stock
SEC:0001179110-22-000388:0·
€56,3161,650 shares@ €34.1310.0009% mcap100.0% of flow
Common Stock
SEC:0001179110-21-008233·
€56,3161,650 shares@ €34.1310.0009% mcap50.0% of flow
Common Stock
SEC:0001179110-21-008233:0·
6 of 6 declarations
About Okey Stephanie
Stephanie Okey is a Director at Crinetics Pharmaceuticals, Inc. and PTC Therapeutics, Inc. She participates in the governance of the companies and in strategic decision-making. Okey brings valuable expertise in the pharmaceutical sector.
